NAYA (NAYA Biosciences Inc) Cumulative Company Assets

Official company branding of NAYA Biosciences Inc (NAYA)

The market trend for NAYA Biosciences (NAYA), which specializes in oncology therapies, as shown on this price chart, demonstrates total assets at 12.33. This price action reflects a high concentration of capital in the development of targeted platforms, which entails binary risks. Global instability impacting biomaterial logistics hinders development, while business success depends on test results and the support of major medical centers.

NAYA Biosciences Inc (NAYA) Aggregate Company Assets: for the period 07/04/2022 - 04/28/2025

Financial and market metric breakdowns for NAYA Bio (NAYA)

- market value and analyst target forecast:
Stock Price nayabiosciences.com|NAYA - Analyst Consensus Forecast
- business market valuation indicators:
Market Valuation NAYA Biosciences Corp|NAYA - Enterprise Value
- company book value details:
Book Value per Share NAYA Biosciences|NAYA - Company Book Value|Capitalization to Book Value Ratio nayabiosciences.com|NAYA - Company Total Assets
- debt burden and liquidity indicators:
Total Debt to Equity Ratio NAYA Biosciences|NAYA - Long-Term Debt to Capital|Current Liabilities to Capital NAYA Biosciences Corp|NAYA - Company Debts|Debt to Net Assets Ratio NAYA Biosciences Corp|NAYA - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings NAYA Biosciences|Quick Liquidity Indicator nayabiosciences.com
- earnings and market multiples details:
NAYA - Net Income
Basic company analysis:nayabiosciences.com (NAYA)
Core merchandise of NAYA Biosciences Inc.

The stability of NAYA Biosciences relies on access to capital for conducting oncology tests, while the total value of resources, reverse-calculated via ROA, reflects the balance between equity and liabilities. It is critical for investors to evaluate this metric as an indicator of financial stability or leverage risk, which the current level of total assets clearly demonstrates.

Key competitors

beigene.com (ONC) - Company Total Assets|HALO (Halozyme) - Company Total Assets|Cumulative Company Assets Revolution Medicines Inc (RVMD)|Company Total Assets AAPG|Company Total Assets CG Oncology Therapeutics (CGON)|Aggregate Company Assets UroGen Pharma Ltd. URGN|BCAX: Total Business Assets|Personalis - Company Total Assets|Erasca Inc (ERAS) - Cumulative Company Assets|DCTH: Company Total Assets|Company Assets Y-mAbs Corp (YMAB)|Aggregate Company Assets Aura Biosciences, Inc.|CADL: Aggregate Asset Value|Cumulative Company Assets ARAY (Accuray)|SLS (sellaslifesciences.com) - Aggregate Asset Value|Company Total Assets ACTU (Actuate Therapeutics, Inc)|CTOR - Cumulative Company Assets|HURA: Cumulative Company Assets|TARA - Company Total Assets|Fate Therapeutics (FATE) - Aggregate Company Assets|Aadi Bioscience - Aggregate Asset Value|TCRX (TScan Therapeutics Inc) - Company Total Assets|Company Assets Champions Oncology Corp CSBR|Aggregate Company Assets XBiotech Inc. (XBIT)|cel-sci.com - Total Business Assets|Company Total Assets OSTX (OS Therapies)|Company Total Assets radiopharmtheranostics.com RADX|ARTV: Cumulative Company Assets|Company Assets Adlai Nortye Ltd.|VERU: Company Total Assets|tempesttx.com (TPST) - Company Total Assets|Cumulative Company Assets XLO|RENB: Aggregate Asset Value|Company Total Assets MURA|Aggregate Company Assets KAPA (kairospharma.com)|Company Total Assets OKUR (OnKure Therapeutics)|Company Total Asset Base CytoMed Therapeutics Ltd (GDTC)|CRIS - Aggregate Company Assets|Company Assets Apollomics, Inc.|Tharimmune Corp (THAR) - Aggregate Company Assets|ADVB - Company Total Asset Base|GNPX (Genprex, Inc.) - Company Total Assets|Cumulative Company Assets Calidi Bio (CLDI)|Company Total Assets SBFM|Company Total Asset Base xeneticbio.com|Company Total Assets SLRX (Salarius)|Kitov Pharma (PPBT) - Company Assets|AONC - Aggregate Company Assets|BGNE (beigene.com) - Total Business Assets|CKPT: Company Total Assets|Cumulative Company Assets elevationoncology.com|ICAD (iCAD Inc.) - Company Total Assets|Company Assets Ikena IKNA|Aggregate Company Assets Notable Labs, Ltd. (NTBL)|Company Total Asset Base viracta.com|Aggregate Company Assets MorphoSys MOR|AAPGV: Total Business Assets